PARAMOUNT Eli Lilly Informed Consent DocumentThe PARAMOUNT trial in NSCLC: is the amount of benefit clinically meaningful?The PARAMOUNT trial: a phase III randomized study of maintenance pemetrexed versus placebo immediately following induction first-line treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer.Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trialPhase II PARAMOUNT trial of LCZ696PARAMOUNT trial: reopening a window to maintenance therapy[PARAMOUNT trial: clinical meaning of continuous maintenance therapy in lung cancer]
P921
Q19022892-8d200cf6-488a-de5b-3c09-d470acdf493fQ41116580-607c87fc-4623-cdbb-75e2-fc99aaa2f028Q45264311-9e150434-4356-c9de-bdc0-e2ba6ebbc0beQ57396177-e2a8dc98-4f16-4a7b-4852-add3cd3ebcb6Q84958268-3846f4c6-4a2f-56ff-0bb9-3100fb7819c7Q87044988-e9dc615f-4be7-27f0-80e4-a759caba9f98Q87348579-5ed5978a-4326-1b32-a3d1-dff06d2ae807
P921
description
clinical trial studying non-small-cell lung carcinoma
@en
klinisch onderzoek
@nl
klinische Studie
@de
name
PARAMOUNT trial
@en
PARAMOUNT-Studie
@de
випробування PARAMOUNT
@uk
type
label
PARAMOUNT trial
@en
PARAMOUNT-Studie
@de
випробування PARAMOUNT
@uk
altLabel
A Phase 3, Double-Blind, Place ...... nt with Pemetrexed + Cisplatin
@en
prefLabel
PARAMOUNT trial
@en
PARAMOUNT-Studie
@de
випробування PARAMOUNT
@uk
P6366
P1476
A Study of Induction and Maint ...... ous Non-Small Cell Lung Cancer
@en
P2175
P3098
NCT00789373
P373
PARAMOUNT trial
P4844
P580
2008-11-01T00:00:00Z
P582
2013-09-01T00:00:00Z
P6366
2778879742